Definitive Contract 75N95021C00024
Award Date
9/24/21
Potential Completion Date
6/23/24
Potential Value
$2M
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St Paul, MN 55114, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Innovative Surface Technologies Inc. (doing business as Isurtec), a small business manufacturer, for $225,000.00 under the Small Business Innovation Research (SBIR) Phase I program. The contract is for research and development of alternatives to commercially available cell culture insert membranes and manufacturing techniques, in...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $225,000.00 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Mattek Corp, a for-profit manufacturer of human tissue models and assay kits. The contract is for the development of electrospun biodegradable membrane inserts, to be performed from July 27, 2020 to April 26, 2021. Mattek previously supported federal biomedical research...
This SBIR Phase I contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Luna Innovations Incorporated, a small business manufacturer, for the development of "RESORB MEMBRANE INSERTS - ADVANCED CELL CULTURE INSERTS WITH BIODEGRADABLE MEMBRANES". The $225,000 firm-fixed-price contract has a period of performance from July 27, 2020 to April 26, 2021. The original solicitation was a total...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Biosurfaces Inc., a for-profit small business, for the delivery of 96-well plate assemblies with a biodegradable membrane. The $894,612.11 firm-fixed-price purchase order contract has a completion date of September 15, 2020. The original solicitation was a combined synopsis/solicitation for commercial items, with the...
This is a $168,400.00 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Biosurfaces Inc., a for-profit organization. The contract is for the acquisition of 96-well transwell plates with proprietary bio-spun membrane inserts. This is a non-competitive award to support NCATS' ongoing use of this manufacturer's specialized cell culture products. The solicitation indicated the...
This is a non-competitive purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Biosurfaces Inc. for 72 units of 96-well transwell plate assemblies with proprietary biodegradable membrane inserts, along with shipping. The $90,000 firm fixed-price contract is intended to support ongoing COVID-19 research at NCATS, which has an established need for these specialized plates from this vendor. Biosurfaces is a...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase II contract to Mimetas US, Inc., a self-certified small disadvantaged business, to develop and evaluate the HEPAPLATE IPS, a high-throughput organ-on-a-chip in vitro hepatotoxicity screening platform. The $1,500,000.00 firm fixed price contract was awarded on February 8, 2018, with a completion date of...
This definitive contract was awarded by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Transmural Systems LLC. The $399,924 firm fixed price contract is for Phase I research under Solicitation A, which sought Small Business Innovation Research (SBIR) proposals in support of NIH and Centers for Disease Control and Prevention (CDC) agency missions. Specifically, Transmural Systems will conduct research and development of a transcatheter...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...